(RTTNews) - Baxter International Inc. (BAX) and Moderna Inc. ( MRNA) said that they have reached an agreement by which Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for about 60-90 million doses of the Moderna COVID-19 Vaccine in 2021. Additional details of the agreement were not disclosed.
Baxter's BioPharma Solutions business is a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals, including vaccines.
The manufacturing of the Moderna COVID-19 vaccine will take place at the BioPharma Solutions fill/finish sterile manufacturing facilities located in Bloomington, Indiana.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
